CD47 and cancer: CD47 is an anti-phagocytic receptor overexpressed in several human cancers and its blockade not only increases phagocytosis of cancer cells in vitro but also promotes activation of T cells against tumours in vivo (Chowdhury et al., 2019; Sockolosky et al., 2016).